Skip to main content
Clinical Medicine logoLink to Clinical Medicine
. 2002 Sep 1;2(5):427–429. doi: 10.7861/clinmedicine.2-5-427

The report of the Chief Medical Officer's CFS/ME working group: what does it say and will it help?

Michael Sharpe 1
PMCID: PMC4953082  PMID: 12448589

Abstract

Chronic fatigue syndrome (CFS) sometimes known as myalgic encephalomyelitis or encephalopathy (ME) has long been a controversial topic. This year has seen the publication of a report from an independent working party set up by the UK Chief Medical Officer (CMO) to make recommendations for the management of the condition. The report makes a number of general recommendations about the provision of appropriate care and services. The more controversial issues of what to call the illness, the nature of the illness and what treatment should be recommended are all addressed, but in the form of compromise rather than resolution. To the extent that this report is a step towards highlighting the needs not only of patients with CFS but the larger group of patients with symptom-defined conditions, it is to be welcomed. As a guide to management it raises as many questions as it answers. Much remains to be resolved before guidance that is both evidence based and acceptable to all parties is achieved.

Keywords: chronic fatigue syndrome, CMO, CBT, graded exercise, patient preference, randomised trials, evidence-based medicine, medically unexplained symptoms

Full Text

The Full Text of this article is available as a PDF (89.3 KB).


Articles from Clinical Medicine are provided here courtesy of Royal College of Physicians

RESOURCES